MAB.WA
Price:
$8.05
Market Cap:
$130.11M
Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.
Industry
Biotechnology
IPO Date
2010-08-10
Stock Exchange
WSE
Ticker
MAB.WA
According to Mabion S.A.’s latest financial reports and current stock price. The company's current ROE is -32.43%. This represents a change of 246.74% compared to the average of -9.35% of the last 4 quarters.
The mean historical ROE of Mabion S.A. over the last ten years is -112.02%. The current -32.43% ROE has changed -71.05% with respect to the historical average. Over the past ten years (40 quarters), MAB.WA's ROE was at its highest in in the September 2019 quarter at 266.07%. The ROE was at its lowest in in the December 2016 quarter at -1322.12%.
Average
-112.02%
Median
16.94%
Minimum
-1497.08%
Maximum
299.85%
Discovering the peaks and valleys of Mabion S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 41.47%
Maximum Annual ROE = 299.85%
Minimum Annual Increase = -283.47%
Minimum Annual ROE = -1497.08%
| Year | ROE | Change |
|---|---|---|
| 2024 | -5.68% | -116.22% |
| 2023 | 35.04% | 15.59% |
| 2022 | 30.31% | 749.24% |
| 2021 | 3.57% | -95.17% |
| 2020 | 73.90% | -75.36% |
| 2019 | 299.85% | -283.47% |
| 2018 | -163.44% | -252.91% |
| 2017 | 106.89% | -107.14% |
| 2016 | -1497.08% | 41.47% |
| 2015 | -3.60% | 705.58% |
The current ROE of Mabion S.A. (MAB.WA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
19.89%
5-year avg
27.43%
10-year avg
-112.02%
Mabion S.A.’s ROE is greater than Poltreg S.A. (-37.19%), greater than Molecure S.A. (-32.20%), greater than NanoGroup S.A. (-57.44%), less than Pure Biologics Spólka Akcyjna (168.05%), greater than Captor Therapeutics Spolka Akcyjna (-77.21%), greater than Genomtec S.A. (-104.44%), greater than Urteste S.A. (-17.38%), less than Medinice S.A. (55.26%), greater than Pharmena S.A. (-15.06%), greater than Airway Medix S.A. (-9.25%),
| Company | ROE | Market cap |
|---|---|---|
| -37.19% | $111.46M | |
| -32.20% | $150.20M | |
| -57.44% | $90.06M | |
| 168.05% | $33.38M | |
| -77.21% | $384.77M | |
| -104.44% | $66.13M | |
| -17.38% | $50.18M | |
| 55.26% | $100.81M | |
| -15.06% | $34.08M | |
| -9.25% | $36.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mabion S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mabion S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Mabion S.A.'s ROE?
How is the ROE calculated for Mabion S.A. (MAB.WA)?
What is the highest ROE for Mabion S.A. (MAB.WA)?
What is the 3-year average ROE for Mabion S.A. (MAB.WA)?
What is the 5-year average ROE for Mabion S.A. (MAB.WA)?
How does the current ROE for Mabion S.A. (MAB.WA) compare to its historical average?